CHARM Therapeutics Bolsters Leadership Team with Key Promotion and Strategic Appointment
LONDON–(BUSINESS WIRE)– CHARM Therapeutics, a 3D deep learning biotechnology company discovering and developing transformational medicines, today announced the promotion of Sarah Skerratt, Ph.D., to Chief...